Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34+CD38- bone marrow cells with multilineage potential at the single-cell level: key role of thrombopoietin.

Purified primitive progenitor/stem cells from bone marrow represent likely target populations for ex vivo expansion of stem cells to be used in high-dose chemotherapy or gene therapy. Whereas such primitive progenitor cells require combined stimulation by multiple cytokines for growth, some cytokines selectively promote viability rather than growth when acting individually. We investigated here for the first time the direct effects of cytokines on survival of primitive CD34+CD38- human bone marrow progenitor cells at the single-cell level. Interleukin-3 (IL-3) and the ligands for c-kit (KL) and flt3 (FL) had direct and selective viability-promoting effects on a small fraction of CD34+CD38- but not CD34+CD38+ progenitor cells. Interestingly, the recently cloned thrombopoietin (Tpo), although stimulating little growth, kept most CD34+CD38- progenitors viable after prolonged culture, maintaining twofold and fourfold more progenitors viable than KL and IL-3, respectively. A high fraction of these progenitors had a combined myeloid and erythroid differentiation potential, as well as capacity for prolonged production of progenitor cells under stroma-independent conditions. In addition, Tpo promoted viability of CD34+CD38- long-term culture-initiating cells, further supporting the idea that Tpo promotes viability of primitive human progenitor cells. Finally, Tpo suppressed apoptosis of CD34+CD38- cells in culture. Thus, the present studies show a novel effect of Tpo, implicating a potential role of this cytokine in maintaining quiescent primitive human progenitor cells viable.

[1]  Z. Darżynkiewicz,et al.  Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. , 1993, Cancer research.

[2]  N. Mahmud,et al.  Activity of the ligand for c‐mpl, thrombopoietin, in early haemopoiesis , 1996, British journal of haematology.

[3]  W. Alexander,et al.  Point mutations within a dimer interface homology domain of c‐Mpl induce constitutive receptor activity and tumorigenicity. , 1995, The EMBO journal.

[4]  I. Weissman,et al.  Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Williams,et al.  Interleukin-1 alpha enhances the in vitro survival of purified murine granulocyte-macrophage progenitor cells in the absence of colony-stimulating factors. , 1988, Blood.

[6]  M. Ogawa,et al.  CD34+ human marrow cells that express low levels of Kit protein are enriched for long-term marrow-engrafting cells. , 1996, Blood.

[7]  W S Alexander,et al.  Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl. , 1996, Blood.

[8]  C. Eaves,et al.  Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[9]  C. Civin,et al.  Sustained, retransplantable, multilineage engraftment of highly purified adult human bone marrow stem cells in vivo. , 1996, Blood.

[10]  S. Jacobsen,et al.  Thrombopoietin, but not erythropoietin promotes viability and inhibits apoptosis of multipotent murine hematopoietic progenitor cells in vitro. , 1996, Blood.

[11]  F. Ruscetti,et al.  Steel factor (c-kit ligand) promotes the survival of hematopoietic stem/progenitor cells in the absence of cell division. , 1995, Blood.

[12]  T. Stokke,et al.  Transforming growth factor-beta potently inhibits the viability- promoting activity of stem cell factor and other cytokines and induces apoptosis of primitive murine hematopoietic progenitor cells , 1995 .

[13]  H. Snoeck,et al.  Interferon gamma selectively inhibits very primitive CD342+CD38- and not more mature CD34+CD38+ human hematopoietic progenitor cells , 1994, The Journal of experimental medicine.

[14]  J. Lotem,et al.  Control of programmed cell death in normal and leukemic cells: new implications for therapy. , 1993, Blood.

[15]  J. Lotem,et al.  Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor beta 1 and cancer chemotherapy compounds in myeloid leukemic cells. , 1992, Blood.

[16]  M. Ogawa,et al.  Differentiation and proliferation of hematopoietic stem cells. , 1993, Blood.

[17]  S. Emerson,et al.  Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: the next generation of cellular therapeutics. , 1996, Blood.

[18]  R. Hoffman,et al.  Human CD34+ HLA-DR- bone marrow cells contain progenitor cells capable of self-renewal, multilineage differentiation, and long-term in vitro hematopoiesis. , 1991, Blood cells.

[19]  G. Crooks,et al.  Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population. , 1996, Blood.

[20]  Lesley J. Murray,et al.  Thrombopoietin stimulates megakaryocytopoiesis, myelopoiesis, and expansion of CD34+ progenitor cells from single CD34+Thy-1+Lin- primitive progenitor cells. , 1996, Blood.

[21]  J. Ihle,et al.  Granulocyte colony-stimulating factor enhances interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[22]  G. Williams,et al.  Apoptosis in the immune system , 1994, The Journal of pathology.

[23]  R. Hoffman,et al.  Characterization of a human hematopoietic progenitor cell capable of forming blast cell containing colonies in vitro. , 1988, The Journal of clinical investigation.

[24]  L. To,et al.  c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture. , 1994, Experimental hematology.

[25]  W. Vainchenker,et al.  Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. , 1993, Blood.

[26]  K. Ikebuchi,et al.  Interleukin-3 and granulocyte colony-stimulating factor as survival factors in murine hemopoietic stem cells in vitro. , 1992, International journal of hematology.

[27]  K. Kaushansky,et al.  Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice. , 1996, Blood.

[28]  G. Johnson,et al.  Stem cell factor enhances the survival but not the self-renewal of murine hematopoietic long-term repopulating cells. , 1994, Blood.

[29]  V. Broudy,et al.  The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells. , 1996, Blood.

[30]  L. Kanz,et al.  Ex vivo expansion of hematopoietic precursor cells , 1996, Current opinion in hematology.

[31]  R. Kastelein,et al.  FLK-2/FLT-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver. , 1995, Blood.

[32]  Y. Hirabayashi,et al.  Promotion of survival and proliferation by interleukin 3, fcil‐ligand and erythropoietin on early and late appearing spleen colony forming units in culture , 1993, Stem cells.

[33]  T. Dexter,et al.  Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis , 1990, Nature.

[34]  D. Metcalf.  Hematopoietic regulators: redundancy or subtlety? , 1993, Blood.

[35]  D. Scadden,et al.  Functional isolation and characterization of human hematopoietic stem cells. , 1995, Science.

[36]  J M Piret,et al.  Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin , 1996, The Journal of experimental medicine.

[37]  K. Kaushansky.  Thrombopoietin the primary regulator of platelet production. , 1995, Trends in endocrinology and metabolism: TEM.

[38]  I. Weissman,et al.  The in vitro response of phenotypically defined mouse stem cells and myeloerythroid progenitors to single or multiple growth factors. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Effects of interleukin-3 and c-kit ligand on the survival of various classes of human hematopoietic progenitor cells. , 1994 .

[40]  M. Ogawa,et al.  Growth factor requirement for survival in cell-cycle dormancy of primitive murine lymphohematopoietic progenitors. , 1993, Blood.

[41]  C. Begley,et al.  The flt3/flk-2 ligand: receptor distribution and action on murine haemopoietic cell survival and proliferation. , 1995, Leukemia.

[42]  D. Lacey,et al.  Pegylated megakaryocyte growth and development factor abrogates the lethal thrombocytopenia associated with carboplatin and irradiation in mice. , 1995, Blood.

[43]  H. Miyazaki,et al.  Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3. , 1996, Blood.

[44]  H. Broxmeyer,et al.  Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice. , 1996, Blood.

[45]  M. Moore.  Review: Stratton Lecture 1990. Clinical implications of positive and negative hematopoietic stem cell regulators. , 1991, Blood.

[46]  S. Karlsson.  Treatment of genetic defects in hematopoietic cell function by gene transfer. , 1991, Blood.

[47]  C. Eaves,et al.  Methodology of long-term culture of human hemopoietic cells , 1991 .

[48]  H. Nakauchi,et al.  Human primitive hematopoietic progenitor cells are more enriched in KITlow cells than in KIThigh cells. , 1993, Blood.

[49]  E. Smeland,et al.  Functional differences between CD38- and DR- subfractions of CD34+ bone marrow cells. , 1994, Blood.

[50]  A. Ritchie,et al.  Thrombopoietin Suppresses Apoptosis and Behaves as a Survival Factor for the Human Growth Factor‐Dependent Cell Line, M07e , 1996, Stem cells.

[51]  G Kvalheim,et al.  Isolation and characterization of human hematopoietic progenitor cells: an effective method for positive selection of CD34+ cells. , 1992, Leukemia.

[52]  M. Koury,et al.  Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. , 1990, Science.

[53]  M. Ogawa,et al.  Growth factor requirements for survival in G0 and entry into the cell cycle of primitive human hemopoietic progenitors. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[54]  P. Lansdorp,et al.  Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells. , 1991, Blood.

[55]  A. Gurney,et al.  Thrombocytopenia in c-mpl-deficient mice. , 1994, Science.

[56]  A. Farese,et al.  Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia. , 1996, The Journal of clinical investigation.

[57]  Lyman Sd.  Biology of flt3 ligand and receptor. , 1995 .

[58]  G. Johnson,et al.  Stem cell factor enhances the survival but not the self-renewal of murine hematopoietic long-term repopulating cells , 1994 .

[59]  D. Bodine,et al.  Effects of hematopoietic growth factors on the survival of primitive stem cells in liquid suspension culture. , 1991, Blood.